FDA Expands Optune's Glioblastoma Multiforme Indication Fantastic news! The FDA acted quickly! They approved Optune for Newly Diagnosed Glioblastoma to be used in addition to the standard treatment!
It results in "the risk of progression or death was reduced by 37 percent "
